Byrd, K., & Truong, P. (2014). Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance. Kansas Journal of Medicine, 7(4), 167-170. https://doi.org/10.17161/kjm.v7i4.11507